Welcome to the 2021 IGCS Meeting Program Scheduling
The meeting will officially run on Central European Time (Rome time-zone, GMT+2)
To convert the meeting times to your local time Click Here
Industry Hall 1
Session Type
Industry Symposia
Room
Industry Hall 1
Date
08/30/2021
Session Description
New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy-Supported by Clinical Care Options, LLC
Session description:
The advent of PARP inhibitors continues to change the treatment paradigm for ovarian cancer with emerging data, guideline updates, new approvals, and expanded indications occurring frequently and expected to continue into the future. Unfortunately, many healthcare professionals do not understand the changing landscape of ovarian cancer therapy, specifically their lack of confidence and experience using PARP inhibitors. This educational symposium aims to update HCPs on the latest clinical trial data, long-term benefits of treatment outcomes and the differences in safety and efficacy profiles of the approved PARP inhibitors.
Industry Symposia
New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy (ID 1069)
Lecture Time
06:50 PM - 06:50 PM
Industry Symposia
Supported by Clinical Care Options, LLC (ID 1070)
Lecture Time
06:50 PM - 06:50 PM
Industry Symposia
Industry Symposia
Advances in ovarian cancer: evolving landscape for PARP inhibitors (ID 1072)
Industry Symposia
Biomarkers in ovarian cancer; BRCA and beyond? (ID 1073)
Industry Symposia
Clinical application of PARP inhibitors based on clinical cases (ID 1074)
Lecture Time
07:15 PM - 07:35 PM
Industry Symposia
Summary, Final thoughts, and Audience Q&A (ID 1076)
Lecture Time
07:35 PM - 07:50 PM